98%
921
2 minutes
20
Background: Pediatric glioma recurrence can cause morbidity and mortality; however, recurrence patterns and severity are heterogeneous and challenging to predict with established clinical and genomic markers. As a result, almost all children undergo frequent, long-term, magnetic resonance imaging (MRI) brain surveillance regardless of individual recurrence risk. Longitudinal deep-learning analysis of serial MRI scans may be an effective approach for improving individualized recurrence prediction in gliomas and other cancers, but, thus far, progress has been limited by data availability and current machine-learning approaches.
Methods: We developed a self-supervised temporal deep-learning approach tailored for longitudinal medical imaging analysis, wherein a multistep model encodes patients' serial MRI scans and is trained to classify the correct chronological order as a pretext task. The pretrained model is then fine-tuned to predict the primary end point of interest - in this case, 1-year recurrence prediction for pediatric gliomas from the point of last scan - by leveraging a patient's historical postoperative surveillance scans. We apply the model across 3994 scans from 715 patients followed at three separate institutions in the setting of pediatric low- and high-grade gliomas.
Results: Longitudinal imaging analysis with temporal learning improved recurrence prediction performance (F1 score) by up to 58.5% (range, 6.6 to 58.5%) compared with traditional approaches across datasets, with performance improvements in both low- and high-grade gliomas and area under the receiver operating characteristic curve of (range, 75 to 89%) across all datasets. Recurrence prediction performance increased incrementally with the number of historical scans available per patient, reaching plateaus between three and six scans, depending on the dataset.
Conclusions: Temporal deep learning enables high-performing longitudinal medical imaging analysis and point-of-care decision support for pediatric brain tumors. Temporal learning may be broadly adaptable to track and predict risk in patients with other cancers and chronic diseases undergoing surveillance imaging. (Funded in part by the National Institutes of Health/National Cancer Institute (U54 CA274516 and P50 CA165962), and Botha-Chan Low Grade Glioma Consortium.).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12176428 | PMC |
http://dx.doi.org/10.1056/aioa2400703 | DOI Listing |
Breast J
September 2025
University of Hawai'i Cancer Center, Honolulu, Hawaii, USA.
The Oncotype DX test is standardly used for patients with early-stage, hormone-receptor-positive, HER2-negative breast cancers to determine the benefit from chemotherapy and the likelihood of distant recurrence. The relationship between Oncotype DX recurrence scores and race/ethnicity is still being studied. This retrospective study aims to evaluate the relationship between Oncotype DX recurrence scores, race/ethnicity, and clinicopathological factors and to support the applicability of the Oncotype DX test for a diverse breast cancer population of Hawaii.
View Article and Find Full Text PDFFront Oncol
August 2025
Department of Surgery, Hebei Medical University, Shijiazhuang, Hebei, China.
Background: Tumor deposit (TD) is an independent risk factor associated with recurrence or metastasis for patients with colorectal cancer (CRC). The scenario in which both TD and lymph node metastasis (LNM) are positive is not clearly illustrated by the current TNM staging system. Simply treating one TD as one or two LNMs by a weighting factor is inappropriate.
View Article and Find Full Text PDFFront Genet
August 2025
Hunan Provincial Key Laboratory of Finance and Economics Big Data Science and Technology, Hunan University of Finance and Economics, Changsha, China.
RNA N4-acetylcytidine (ac4C) is a crucial chemical modification involved in various biological processes, influencing RNA properties and functions. Accurate prediction of RNA ac4C sites is essential for understanding the roles of RNA molecules in gene expression and cellular regulation. While existing methods have made progress in ac4C site prediction, they still struggle with limited accuracy and generalization.
View Article and Find Full Text PDFEClinicalMedicine
October 2025
Department of Cardiothoracic Surgery, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, China.
Background: Paediatric patients who underwent surgery for mitral regurgitation (MR) have a high risk of recurrence or death; however, no prediction tool has been developed to risk-stratify this challenging subpopulation.
Methods: In this multicentre cohort study, paediatric patients undergoing surgery for congenital MR in Shanghai Children's Medical Center in January 1st, 2009-December 31st, 2022 were included for analysis while those had a combination with infective endocarditis, anomalous left coronary artery from the pulmonary artery, rheumatic valvular disease, connective tissue disease, or single ventricle were excluded. A Cox regression model predictive of the primary outcome (a composite of mortality or mitral valve [MV] re-operation) was derived and converted to a point-based risk score.
Front Physiol
August 2025
Department of Ultrasound, Deyang People's Hospital, Deyang, Sichuan, China.
Background: Antiphospholipid syndrome (APS) is a major immune-related disorder that leads to adverse pregnancy outcomes (APO), including recurrent miscarriage, placental abruption, preterm birth, and fetal growth restriction. Antiphospholipid antibodies (aPLs), particularly anticardiolipin antibodies (aCL), anti-β2-glycoprotein I antibodies (aβ2GP1), and lupus anticoagulant (LA), are considered key biomarkers for APS and are closely associated with adverse pregnancy outcomes. This is a prospective observational cohort study to use machine learning model to predict adverse pregnancy outcomes in APS patients using early pregnancy aPL levels and clinical features.
View Article and Find Full Text PDF